Denosumab biosimilar is under clinical development by Sandoz Group and currently in Pre-Registration for Giant Cell Tumor Of Bone.
‘Yellow’ Blood Products Come With VTE Risk, Study Finds
SAN FRANCISCO — Surgeons should be extremely judicious in ordering fresh frozen plasma (FFP) as part of perioperative blood transfusions, suggested a nationwide analysis reported